drugset / Trial / NCT07331402
A Clinical Study Evaluating the Pharmacokinetics and Pharmacodynamics of HSK39004 Inhalation Suspension in COPD Patients
RandomizedCrossoverQuadruple-blindTreatment
Summary
This is a random, single blind, positive control, crossover design clinical study to evaluate the pharmacokinetics and pharmacodynamics of HSK39004 inhalation suspension in COPD patients
Timeline
- Start
- 2025-07-28
- Primary completion
- 2025-12-30
- Completion
- 2026-08-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HSK39004 | Unknown | 3 mg | Inhaled |
| Subject | Ohtuvayre | Unknown | 3 mg | Inhaled |